RT Journal Article SR Electronic T1 Early prediction of renal graft function: Analysis of a multi-centre, multi-level data set JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.04.20248473 DO 10.1101/2021.01.04.20248473 A1 Blazquez-Navarro, Arturo A1 Bauer, Chris A1 Wittenbrink, Nicole A1 Wolk, Kerstin A1 Sabat, Robert A1 Dang-Heine, Chantip A1 Neumann, Sindy A1 Roch, Toralf A1 Wehler, Patrizia A1 Blazquez-Navarro, Rodrigo A1 Olek, Sven A1 Thomusch, Oliver A1 Seitz, Harald A1 Reinke, Petra A1 Hugo, Christian A1 Sawitzki, Birgit A1 Babel, Nina A1 Or-Guil, Michal YR 2021 UL http://medrxiv.org/content/early/2021/01/05/2021.01.04.20248473.abstract AB Introduction Long-term graft survival rates after renal transplantation are still moderate. We aimed to build an early predictor of an established long-term outcomes marker, the glomerular filtration rate (eGFR) one year post-transplant (eGFR-1y).Materials and Methods A large cohort of 376 patients was characterized for a multi-level bio-marker panel including gene expression, cytokines, metabolomics and antibody reactivity profiles. Almost one thousand samples from the pre-transplant and early post-transplant period were analysed. Machine learning-based predictors were built employing stacked generalization.Results Pre-transplant data led to a prediction achieving a Pearson’s correlation coefficient of r=0.39 between measured and predicted eGFR-1y. Two weeks post-transplant, the correlation was improved to r=0.63, and at the third month, to r=0.76. eGFR values were remarkably stable throughout the first year post-transplant and were the best estimators of eGFR-1y already two weeks post-transplant. Several markers were associated with eGFR: The cytokine stem cell factor demonstrated a strong negative correlation; and a subset of 19 NMR bins of the urine metabolome data was shown to have potential applications in non-invasive eGFR monitoring. Importantly, we identified the expression of the genes TMEM176B and HMMR as potential prognostic markers for changes in the eGFR.Discussion Our multi-centre, multi-level data set represents a milestone in the efforts to predict transplant outcome. While an acceptable predictive capacity was achieved, we are still very far from predicting changes in the eGFR precisely. Further studies employing further marker panels are needed in order to establish predictors of eGFR-1y for clinical application; herein, gene expression markers seem to hold the most promise.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT 00724022Funding StatementThis work was funded by the German Federal Ministry of Education and Research (BMBF), project e:KID (01ZX1312). The funders had no role in data collection, data analysis, data interpretation, writing of the manuscript, or manuscript submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We characterized the patient cohort of the randomized, multi-centre Harmony trial (NCT 00724022). The study was carried out in compliance with the Declaration of Helsinki and Good Clinical Practice. The trial was approved by the Ethics Committee of the Gustav Carus Technical University Dresden.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets for this article are not publicly available because the patients have not consented to the publication of their data. Requests for limited access to the data should be directed to Nina Babel, (nina.babel{at}charite.de).